Wednesday, January 19, 2011

In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus

In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus

Hepatitis C is a major health problem causes liver cirrhosis, hepatocellular carcinoma and death. The current treatment of standard interferon in combination with ribavirin, has limited benefits due to emergence of resistant mutations during long-term treatment, adverse side effects and high cost.

Hence, there is a need for the development of more effective, less toxic antiviral agents.

Results: The present study was designed to search anti-HCV plants from different areas of Pakistan. Ten medicinal plants were collected and tested for anti-HCV activity by infecting the liver cells with HCV 3a innoculum.

Methanol and chloroform extracts of Solanum nigrum (SN) seeds exhibited 37% and more than 50% inhibition of HCV respectively at non toxic concentration. Moreover, antiviral effect of SN seeds extract was also analyzed against HCV NS3 protease by transfecting HCV NS3 protease plasmid into liver cells.

The results demonstrated that chloroform extract of SN decreased the expression or function of HCV NS3 protease in a dose- dependent manner and GAPDH remained constant.

Conclusion: These results suggest that SN extract contains potential antiviral agents against HCV and combination of SN extract with interferon will be better option to treat chronic HCV.

Author: Tariq JavedUsman AshfaqSana RiazSidra RehmanSheikh Riazuddin
Credits/Source: Virology Journal 2011, 8:26

No comments:

Post a Comment